Prion protein (PrP) is a cell surface glycoprotein predominantly expressed in the central nervous system, especially in neurons. While the precise physiological function of PrP remains an active area of research, it is best known for its association with a group of neurodegenerative diseases termed prion diseases. These conditions arise when the normally folded form of PrP, denoted as PrP^C (cellular prion protein), undergoes a conformational change to become a misfolded, disease-associated form, termed PrP^Sc (scrapie prion protein). The accumulation of PrP^Sc in neural tissues can lead to neuronal damage and is the hallmark of prion diseases. However, the native, correctly folded PrP^C is believed to play roles in cell adhesion, protection against oxidative stress, and modulation of neuronal excitability, emphasizing the protein's significance beyond its pathological implications.
Activators of PrP are molecules or compounds that enhance the expression, stability, or activity of the PrP protein. These activators might function by promoting the transcription or translation of the PRNP gene (which encodes PrP), stabilizing the correctly folded conformation of PrP^C, or enhancing its interaction with binding partners and co-factors. The presence of PrP activators can influence the dynamics of PrP^C in cellular systems, modulating its physiological functions and interactions within neural tissues. Diving into the realm of PrP activators offers a glimpse into the intricate world of protein folding, conformational dynamics, and the molecular underpinnings that shape neuronal function. As the mosaic of cellular biochemistry and neurobiology continues to be pieced together, the role of PrP and its activators emerges as a captivating chapter, revealing the delicate balance of protein dynamics that sustain neural health and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Studied for its antimalarial properties, Quinacrine may prevent the accumulation of PrPSc. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Has been shown to interfere with the PrPSc formation process. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $70.00 $142.00 $223.00 | 10 | |
Demonstrated to inhibit the conversion of PrPC to PrPSc. | ||||||
Acridine | 260-94-6 | sc-214485 sc-214485A | 5 g 25 g | $56.00 $206.00 | 2 | |
May interfere with the PrPSc accumulation process. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Studied for its antipsychotic properties, Chlorpromazine may inhibit the accumulation of PrPSc. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $116.00 $230.00 | 12 | |
Identified as a potential inhibitor of PrPSc formation. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Considered a nonsteroidal anti-inflammatory compound that may influence PRNP expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A natural compound that may downregulate PRNP expression and reduce PrPSc accumulation. | ||||||